Latest filing published 03 Feb 2023 for Diffusion Pharmaceuticals Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Robert Joseph Cobuzzi Jr.: trading record in brief
This profile gathers the share dealings of Robert Joseph Cobuzzi Jr. in CervoMed Inc., where the filings describe the role as chief executive. Over a trading history stretching from 16 November 2020 to 31 January 2023, the count stands at 15 filings.
No open-market sale appears; the market trades are 1 purchase worth €7,801. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 7 option exercises.
Most recently, on 3 February 2023, the filings show a transaction in CervoMed Inc. The latest purchase dates back some time: it was published 2,182 days ago, on 18 November 2020. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Robert Joseph Cobuzzi Jr.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 327 sharesCommon StockSEC:0001437749-23-002473:0
- 327 sharesCommon StockSEC:0001437749-22-025572:0
- 327 sharesCommon StockSEC:0001437749-22-018666:0
- 327 sharesCommon StockSEC:0001437749-22-010718:0
- 100 shares@ US$25.00100.0% of flowCommon StockSEC:0001437749-22-009234:0
- 16,350 sharesCommon StockSEC:0001437749-22-002263:0
- 16,350 sharesCommon StockSEC:0001437749-22-002262:0
- 16,350 sharesCommon StockSEC:0001437749-21-025138:0
8 of 8 declarations
